GLRA2 and epilepsy: It may be possible that glycine receptor alpha 2 (GLRA2), with a heightened intracerebral expression and linked to epilepsy is the pathway through which miR-27a-3p operates, an aspect that may also be extrapolated to CCM-induced seizures.